Similarly, Zhu et al. demonstrated that perhexiline inhibited phosphorylation of Akt and other downstream HER3 activation markers in NKX2-8-deleted (NKX2-8+/−) CAOV3 and OVCAR3 epithelial ovarian cancer (EOC) cells [33]. Here, NKX2-8 is linked to ovarian carcinoma.